US Patent:
20050227917, Oct 13, 2005
Inventors:
Lewis Williams - Emeryville CA, US
Jaime Escobedo - Emeryville CA, US
Michael Innis - Emeryville CA, US
Pablo Garcia - Emeryville CA, US
Julie Sudduth-Klinger - Emeryville CA, US
Christoph Reinhard - Emeryville CA, US
Klaus Giese - Emeryville CA, US
Filippo Randazzo - Emeryville CA, US
Giulia Kennedy - Emeryville CA, US
David Pot - Emeryville CA, US
Altaf Kassam - Emeryville CA, US
George Lamson - Emeryville CA, US
Zhijun He - Emeryville CA, US
Elizabeth Scott - Emeryville CA, US
Guozhong Zhang - Emeryville CA, US
Theresa May - Emeryville CA, US
Doreen Sakamoto - Emeryville CA, US
Radoje Drmanac - Sunnyvale CA, US
Radomir Crkvenjakov - Sunnyvale CA, US
Mark Dickson - Sunnyvale CA, US
Snezana Drmanac - Sunnyvale CA, US
Ivan Labat - Sunnyvale CA, US
Dena Leshkowitz - Sunnyvale CA, US
David Kita - Sunnyvale CA, US
Veronica Garcia - Sunnyvale CA, US
Lee Jones - Sunnyvale CA, US
International Classification:
C12Q001/68
C07K014/47
A61K038/17
C07H021/04
US Classification:
514012000, 435006000, 435069100, 435320100, 435325000, 530350000, 536023500
Abstract:
The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.